Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.

There was a statistical trend toward enrichment of pre-alloHCT CK in those who died within 1 year of alloHCT compared with longer term survival (48.3% vs 33.3%; P = .063), though it did not meet the prespecified threshold for significance.

also in 745 other papers